These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21762806)

  • 1. HIV-1 matrix protein binding to RNA.
    Alfadhli A; McNett H; Tsagli S; Bächinger HP; Peyton DH; Barklis E
    J Mol Biol; 2011 Jul; 410(4):653-66. PubMed ID: 21762806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.
    Alfadhli A; Staubus AO; Tedbury PR; Novikova M; Freed EO; Barklis E
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids.
    Alfadhli A; Still A; Barklis E
    J Virol; 2009 Dec; 83(23):12196-203. PubMed ID: 19776118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
    Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
    J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between MA-RNA Binding in Cells and Suppression of HIV-1 Gag Mislocalization to Intracellular Membranes.
    Thornhill D; Olety B; Ono A
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate.
    Alfadhli A; Barklis RL; Barklis E
    Virology; 2009 May; 387(2):466-72. PubMed ID: 19327811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane Binding of HIV-1 Matrix Protein: Dependence on Bilayer Composition and Protein Lipidation.
    Barros M; Heinrich F; Datta SAK; Rein A; Karageorgos I; Nanda H; Lösche M
    J Virol; 2016 May; 90(9):4544-4555. PubMed ID: 26912608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of small molecule ligands targeting the HIV-1 matrix protein-RNA binding site.
    Alfadhli A; McNett H; Eccles J; Tsagli S; Noviello C; Sloan R; López CS; Peyton DH; Barklis E
    J Biol Chem; 2013 Jan; 288(1):666-76. PubMed ID: 23135280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.
    Chukkapalli V; Oh SJ; Ono A
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1600-5. PubMed ID: 20080620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane binding and subcellular localization of retroviral Gag proteins are differentially regulated by MA interactions with phosphatidylinositol-(4,5)-bisphosphate and RNA.
    Inlora J; Collins DR; Trubin ME; Chung JY; Ono A
    mBio; 2014 Dec; 5(6):e02202. PubMed ID: 25491356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Matrix Protein Interactions with tRNA: Implications for Membrane Targeting.
    Gaines CR; Tkacik E; Rivera-Oven A; Somani P; Achimovich A; Alabi T; Zhu A; Getachew N; Yang AL; McDonough M; Hawkins T; Spadaro Z; Summers MF
    J Mol Biol; 2018 Jul; 430(14):2113-2127. PubMed ID: 29752967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.
    Jones CP; Datta SA; Rein A; Rouzina I; Musier-Forsyth K
    J Virol; 2011 Feb; 85(4):1594-603. PubMed ID: 21123373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The matrix domain contributes to the nucleic acid chaperone activity of HIV-2 Gag.
    Pachulska-Wieczorek K; Błaszczyk L; Biesiada M; Adamiak RW; Purzycka KJ
    Retrovirology; 2016 Mar; 13():18. PubMed ID: 26987314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of lipids and nucleic acids in HIV-1 assembly.
    Alfadhli A; Barklis E
    Front Microbiol; 2014; 5():253. PubMed ID: 24917853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and Molecular Determinants of Membrane Binding by the HIV-1 Matrix Protein.
    Mercredi PY; Bucca N; Loeliger B; Gaines CR; Mehta M; Bhargava P; Tedbury PR; Charlier L; Floquet N; Muriaux D; Favard C; Sanders CR; Freed EO; Marchant J; Summers MF
    J Mol Biol; 2016 Apr; 428(8):1637-55. PubMed ID: 26992353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants that regulate plasma membrane association of HIV-1 Gag.
    Chukkapalli V; Ono A
    J Mol Biol; 2011 Jul; 410(4):512-24. PubMed ID: 21762797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
    Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
    J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIV-1 Gag-membrane interactions by specific RNAs.
    Todd GC; Duchon A; Inlora J; Olson ED; Musier-Forsyth K; Ono A
    RNA; 2017 Mar; 23(3):395-405. PubMed ID: 27932583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 matrix mutations that alter gag membrane binding modulate mature core formation and post-entry events.
    Hikichi Y; Takeda E; Fujino M; Nakayama E; Matano T; Murakami T
    Virology; 2019 Jun; 532():97-107. PubMed ID: 31055063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.